A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
Public ClinicalTrials.gov record NCT07724340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-Controlled, Multi-center Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
Study identification
- NCT ID
- NCT07724340
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Antag Therapeutics
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Interventions
- AT673 low dose Drug
- AT673 high dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2026
- Primary completion
- Jan 31, 2027
- Completion
- Feb 28, 2027
- Last update posted
- Jul 23, 2026
2026 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CenExel Phoenix | Chandler | Arizona | 85224 | Recruiting |
| CenExel Anaheim | Anaheim | California | 92801 | Recruiting |
| CenExel Hollywood | Hollywood | Florida | 33024 | Recruiting |
| CenExel Tampa | Tampa | Florida | 33613 | Recruiting |
| CenExel Atlanta | Atlanta | Georgia | 30331 | Recruiting |
| CenExel Decatur | Decatur | Georgia | 30030 | Recruiting |
| CenExel Savannah | Savannah | Georgia | 31405 | Recruiting |
| CenExel SLC | Salt Lake City | Utah | 84107 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07724340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07724340 live on ClinicalTrials.gov.